MIP⁃1ɑ antagonist combined with bortezomib promotes osteoblasts in myeloma bone disease by inhibiting Erk1/2/Bax 

CHEN Weiqiong, JIANG Fang, WANG Shanshan, HUANG Bo, QU Fujun, HUANG Lin, WANG Xiaotao.
The Journal of Practical Medicine . 2021, (12): 1529 -1533 .  DOI: 10.3969/j.issn.1006⁃5725.2021.12.004